4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001615774-16-007354
Director acquired 2,058 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Harris Geoffrey E. Director | 2016-09-21 | Option exercise | +2,058 | $5.00 | $10,290 | 4,558 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Harris Geoffrey E. Director | 2016-09-21 | Option exercise · 5% Secured Convertible Note due December 2017 | −0 | D: show line 2 in the form | ||||||
| Harris Geoffrey E. Director | 2016-09-21 | Returned to the company · Common Stock Warrant | −0 | 0 | D: show line 3 in the form |
Loading xslF345X03/s104196_form4.xml…